Precision Medicine for Neonatal Sepsis

Area of Science:

• Biomedical Science
• Genomics
• Proteomics
• Metabolomics

Background:

• Neonatal sepsis is a major cause of illness and death in preterm infants.
• Current diagnostic methods for neonatal sepsis are often challenging and lack accuracy.
• High-throughput molecular technologies are being explored for improved sepsis diagnosis.

Purpose of the Study:

• To review the applications of omics-based analyses for identifying new biomarkers and diagnostic signatures for neonatal sepsis.
• To focus on the immune-compromised preterm infant population.
• To discuss considerations for clinical translation of omics findings.

Main Methods:

• Review of recent omics-based studies (transcriptomic, proteomic, metabolomic).
• Analysis of systems biology approaches for understanding neonatal sepsis.
• Examination of challenges in integrating multi-omic data with clinical and laboratory metadata.

Main Results:

• Omics technologies can provide a systems-level understanding of neonatal sepsis.
• Distinct transcriptional signatures and metabolic/proteomic biomarkers associated with sepsis have been identified.
• Omics-based approaches show promise for advancing diagnostic tools for neonatal sepsis.

Conclusions:

• Omics-based analytical approaches hold potential for improving neonatal sepsis diagnostics.
• Further research is needed to validate systems biology findings and integrate multi-dimensional data.
• Translating these findings into precision medicine for neonatal sepsis requires addressing data integration challenges.